PROJECT DESCRIPTION

OnceMRK was a double-blind, placebo-controlled study in 797 treatment naive participants. Materials produced for recruitment and retention of subjects for 96-week duration. The study drug was approved based on 48-week results. 

Brochure, flyer, various patient retention materials, digital display advertising, patient ClinKit app.